ERBB2 and invasive lobular breast carcinoma: We applied the factor analysis pipeline to a human invasive lobular carcinoma breast tissue (estrogen receptor positive, progesterone receptor positive, and HER2 negative) dataset [35] that contains transcriptomics measurements profiled across 4325 spots.